NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse
Authors:
- Sarah ClarkeSCSarah Clarke
- 1 July 2011
- journal article
- other
- Published by Elsevier in Leukemia Research
- Vol. 35 (7) , e131-e133
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemiaLeukemia, 2008
- Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemiaLeukemia, 2008
- Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignanciesLeukemia, 2008
- Fusion of NUP214 to ABL1 on amplified episomes in T-ALL – implications for treatmentLeukemia, 2005
- NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significanceLeukemia, 2005
- Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemiaNature Genetics, 2004